Burra Vijitha, Nagaraja P S, Singh Naveen G, Prabhakar V, Manjunatha N
Department of Cardiac Anaesthesiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.
Ann Card Anaesth. 2018 Oct-Dec;21(4):455-459. doi: 10.4103/aca.ACA_14_18.
Acute kidney injury (AKI) is a strong predictor of morbidity and mortality after cardiac surgery. Lack of valid early biomarkers for predicting AKI has hampered the ability to take therapeutic measures for preventive cause. Hyperphosphatemia that occurs in AKI due to renal excretion defect was not studied in this context and could be simple marker of AKI. Therefore, we tested role of serum phosphorus in prediction of AKI as a biomarker after cardiac surgery in children.
We prospectively evaluated 51 children aged between 3 weeks and 12 years undergoing elective cardiac surgery. Serum creatinine and phosphorus were measured preoperatively and postoperatively at 24 and 48 h. As per the Kidney Disease Improving Global Outcomes criteria, patients were grouped into AKI and non-AKI on the basis of the development of AKI within 48 h postsurgery. The postoperative diagnostic performance of phosphorus thresholds was analyzed by the area under receiver operating characteristic curves (AUC-ROC).
From 51 children included, 10 developed AKI. In AKI group, serum phosphorus increased significantly from 4.47 ± 0.43 baseline to 6.29 ± 0.32 at 24 h postsurgery (P = 0.01) while serum creatinine increased from baseline 0.33 (0.24-0.46) to 0.49 (0.26-0.91) at 24 h which is statistically insignificant (P = 0.16). ROC analysis showed that serum phosphorus at 24 h, the AUC was 0.84 with sensitivity 0.75 and specificity 0.93 for a cutoff value of 6.4 mg/dl. Whereas serum phosphorus at 48 h, the AUC was 0.86 with sensitivity 66.67% and specificity 97.62% for a cutoff value of 5.4 mg/dl.
Serum phosphorus can be an alternative biomarker as early as 24 h for early prediction of AKI in pediatric cardiac surgery.
急性肾损伤(AKI)是心脏手术后发病率和死亡率的有力预测指标。缺乏用于预测AKI的有效早期生物标志物阻碍了采取预防措施的治疗能力。因肾脏排泄缺陷而发生在AKI中的高磷血症在此背景下未被研究,且可能是AKI的简单标志物。因此,我们测试了血清磷作为儿童心脏手术后AKI预测生物标志物的作用。
我们前瞻性评估了51名年龄在3周至12岁之间接受择期心脏手术的儿童。术前以及术后24小时和48小时测量血清肌酐和磷。根据改善全球肾脏病预后组织的标准,根据术后48小时内AKI的发生情况将患者分为AKI组和非AKI组。通过受试者操作特征曲线下面积(AUC-ROC)分析磷阈值的术后诊断性能。
在纳入的51名儿童中,10名发生了AKI。在AKI组中,血清磷从基线时的4.47±0.43显著增加至术后24小时的6.29±0.32(P = 0.01),而血清肌酐从基线时的0.33(0.24 - 0.46)增加至24小时时的0.49(0.26 - 0.91),差异无统计学意义(P = 0.16)。ROC分析显示,术后24小时血清磷的AUC为0.84,对于截断值6.4mg/dl,敏感性为0.75,特异性为0.93。而术后48小时血清磷的AUC为0.86,对于截断值5.4mg/dl,敏感性为66.67%,特异性为97.62%。
血清磷可作为一种替代生物标志物,早在术后24小时就能早期预测小儿心脏手术中的AKI。